Viritis

Biotech company pioneering a next-generation antisense-based platform for rapid development of antiviral drugs.

Health Tech & Life Sciences
Active
Pre-Seed Petah Tikva, Israel Founded 2020
Last updated 2026-07-20
Total raised
$500K
Last: Grant 2025-02
Stage
Pre-Seed
Founded
2020
Headcount
5
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

Viritis is a biotech company pioneering a next-generation antisense-based platform for rapid development of antiviral drugs. Their novel technology targets all strains of a given virus, offering a scalable and precise solution for current and emerging viral threats. The platform combines AI-driven algorithms with patented molecule design to bind specifically to viral RNA, activating the cell's innate defense mechanisms to degrade the virus from within without harming the host. The molecule naturally disintegrates within hours, leaving no harmful residues. In POC studies, their platform demonstrated 97.1% cellular protection against the target virus. Its innovative structure also makes it highly stable, can be lyophilized, and easy to store and transport—ideal for global deployment.

Funding history · 4 rounds · $500K total

2025-01
Grant $500K
2025-01
A Round Undisclosed
★ Road2
2023-02
Seed Undisclosed
2022-03
Pre-Seed Undisclosed

Headcount over time

From 3 (2022-10) to 3 (2026-01) · +0 (+0%) · 8 points · source: Finder history + radar grounding
40 2022-10 2026-01

Q&A

What is Viritis's primary focus?
Viritis is a biotech company focused on pioneering next-generation antisense-based antiviral treatments, utilizing an AI-driven platform to develop drugs that target all strains of a given virus.
When was Viritis founded?
Viritis was founded in August 2020.
What is Viritis's current funding stage?
Viritis is currently in the Pre-Seed funding stage.
What was Viritis's most recent funding round?
In February 2025, Viritis received a Grant of $500,000. In the same month, they also raised $85,000 from investor Road2.
What is the total amount of funding Viritis has raised to date?
Viritis has raised a total of $665,000 USD.
Who are the co-founders of Viritis?
The co-founders of Viritis include Aaron Wis (Chairman), Amit Turman (Co-founder & CEO), and Amit Philosoph (Chief Scientist).
Does Viritis hold any patents?
Yes, Viritis holds one patent.

Team · 2

Amit Turman
Founder · Co-founder & CEO
Amit Philosoph
Founder · Chief Scientist

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMaterials & SubstancesNanomaterialsBiologicalsCellsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

pharmaceuticalsvaccinesoral-drugstherapeuticsdrug-deliverytreatmentsviral-diseasesbiotechnologybiopharmaceuticaldrug-designnanotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteviritis.org/
LinkedInlinkedin.com/company/70943980

Identifiers & details

Legal nameVIRITIS LTD
Founded2020-8
Employees (exact)5

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainviritis.org

Certificate / subdomain footprint

Subdomains6

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516246444
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2020-08-31
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events0
Registered addressהעוגב 49 פתח תקווה